CDG Invest Growth invests in the capital of companies in Morocco and Africa

CDG Invest Growth exits Steripharma, a pharmaceutical business in Morocco

CDG Invest Growth announced its exit from Laboratoires Steripharma, a well-established pharmaceutical business in Morocco through a strategic sale.

Steripharma was founded in 1999 and has since developed a large portfolio of drugs with strong recognition among patients and practitioners. The Company has its own range of medicines (generics) and also produces/distributes drugs under license for leading international laboratories. Its product range covers major therapeutic areas, including infectiology and parasitology, cardiology, respiratory system, digestive system, dental care, ophthalmology and dermatology.

Click here for more information about Steripharma

In December 2014, CDG Invest Growth exited JUICE AND NECTAR PARTNERS (JNP), the latest investment of the Accès Capital Atlantique Maroc S.A (ACAMSA) Fund.The withdrawal of JNP, a producer of organic juice mainly for export, was carried out to the benefit of the HOLMARCOM Group, a major operator in the Moroccan economy. This sale operation […]

CDG Invest Growth takes a stake in T2S (Techniques Science Santé), Morocco’s leading distributor of high tech medical equipment. T2S, the leader in the distribution and the maintenance of medical equipment Founded in 1992, T2S assists healthcare professionals in the installation, training for utilisation and maintenance of high technology medical equipment. T2S distributes in Morocco […]

CDG Invest Growth, the leading growth equity investor in Morocco invested in Group Oncorad, a private healthcare provider focused on oncology and radiology. Oncorad was founded in 1999 by Pr. Redouane Samlali and Dr. Omar Hajji.  Their first center was Clinique le Littoral which opened in 2000 in Casablanca. Through the years, Clinique le Littoral […]